Am.  Jour.  Pharm.  ) 
July,  1909.  J 
A  in  erica  n  Medical  Association. 
359 
man,  Dr.  William  Allen  Pusey,  discussed  the  relations  between 
dermatology  and.  the  Pharmacopoeia. 
Mr.  Geo.  M.  Beringer,  as  chairman  of  the  delegates  of  the 
American  Pharmaceutical  Association,  presented  the  felicitations  of 
the  members  of  that  organization  and  pointed  out  how  members  of 
the  Section  on  Pharmacology  and  Therapeutics  might  be  of  service 
in  the  revising  of  the  National  Formulary  and  thus  promoting  the 
progress  of  the  sciences  relating  to  pharmacy.  At  a  subsequent 
meeting  the  recommendations  made  by  Mr.  Beringer  were  consid- 
ered and,  on  motion,  the  incoming  chairman  of  the  section  was  re- 
quested to  appoint  a  committee  of  five  to  consider  the  National 
Formulary  and  the  advisability  of  retaining  or  deleting  the  several 
preparations  now  included  in  that  book. 
Both  of  the  sessions  on  Thursday,  June  10,  1909,  were  devoted 
to  the  discussion  of  problems  relating  to  the  Pharmacopoeia  and 
National  Formulary  and  pages  of  this  Journal  would  be  required 
to  adequately  reflect  all  of  the  interesting  material  that  was  pre- 
sented. The  report  of  the  A.  M.  A.  committee  on  the  United 
States  Pharmacopoeia  included  a  review  of  the  several  lines  along 
which  medical  organizations  are  preparing  to  take  an  active  part  in 
the  coming  revision  of  that  book  and  outlined  a  plan  for  correlating 
these  several  lines  of  activity  in  a  practical  way,  and  thus  promote 
the  work  and  avoid  unnecessary  duplication. 
C.  S.  N.  Flallberg,  Chicago,  presented  an  interesting  communica- 
tion on  additions  to  and  eliminations  from  the  Pharmacopoeia  of 
the  United  States  from  the  viewpoints  of  statistics.  Another  com- 
munication bearing  on  the  same  subject  was  a  discussion  of  some 
of  the  preparations  of  the  United  States  Pharmacopoeia  from  the 
practitioner's  standpoint,  by  M,  IT.  Fussell,  Philadelphia. 
L.  F.  Kebler,  Washington,  discussed  the  nomenclature  of  the 
United  States  Pharmacopoeia  and  National  Formulary  mixtures  and 
also  presented  a  communication  on  the  nature  of  preparations  used 
in  the  treatment  of  drug  addictions. 
A  paper  by  Henry  Leffmann,  Philadelphia,  on  "  What  can 
Physicians  do  to  Improve  the  Pharmacopoeia,"  brought  out  the  asser- 
tion, by  one  of  the  members  present,  that  the  writer  of  the  paper 
had  on  two  occasions  been  nominated  as  a  delegate  to  the  national 
convention  and  had  failed  to  attend  the  meeting.  The  critic  of  the 
paper  pointed  out  that  physicians  could  do  much  to  improve  the 
Pharmacopoeia  if  they  would  carefully  consider  its  needs  and  short- 
